As with any surgery, there are risks, such as infection, seroma (fluid accumulation), deep vein thrombosis (DVT), changes in skin sensation, or asymmetry
Works by promoting angiogenesis and cellular repair mechanisms in connective tissues
In the TRIUMPH-1 obesity trial (topline 21 May 2026), the 12 mg dose produced a mean weight loss of roughly 28% at 80 weeks in patients without diabetes, extending to close to 30% by 104 weeks in a severe-obesity extension cohort among the largest sustained pharmacological weight-loss effects reported in any trial to date
The cancelled Phase I trial that would have tested oral BPC-157 in 42 healthy volunteers never published results, leaving that data inaccessible
Microcirculation disturbance affects rats with acute severe pancreatitis following lung injury
Season with garlic salt